Silencing of FOS-like antigen 1 represses restenosis via the ERK/AP-1 pathway in type 2 diabetic mice

1. Larsson, SC, Wallin, A, Hakansson, N, et al. Type 1 and type 2 diabetes mellitus and incidence of seven cardiovascular diseases. Int J Cardiol 2018; 262: 66–70. DOI: 10.1016/j.ijcard.2018.03.099.
Google Scholar | Crossref | Medline2. Jukema, JW, Verschuren, JJ, Ahmed, TA, et al. Restenosis after PCI. Part 1: pathophysiology and risk factors. Nat Rev Cardiol 2011; 9: 53–62. DOI: 10.1038/nrcardio.2011.132.
Google Scholar | Crossref | Medline | ISI3. Hui, S, Choi, J, Zaidi, S, et al. Peptide-mediated disruption of calmodulin-cyclin E interactions inhibits proliferation of vascular smooth muscle cells and neointima formation. Circ Res 2011; 108: 1053–1062. DOI: 10.1161/CIRCRESAHA.110.239483.
Google Scholar | Crossref | Medline4. Xu, Y, Wang, L, Liu, J. miR-130a inhibits cell viability and migration through FOSL1 in lung cancer. J Biol Regul Homeost Agents 2020; 34: 2020. DOI: 10.23812/20-13L 19.
Google Scholar5. Luo, YZ, He, P, Qiu, MX. FOSL1 enhances growth and metastasis of human prostate cancer cells through epithelial mesenchymal transition pathway. Eur Rev Med Pharmacol Sci 2018; 22: 8609–8615. DOI: 10.26355/eurrev_201812_16624.
Google Scholar | Crossref | Medline6. Chen, X, Zhao, M, Huang, J, et al. microRNA-130a suppresses breast cancer cell migration and invasion by targeting FOSL1 and upregulating ZO-1. J Cel Biochem 2018; 119: 4945–4956. DOI: 10.1002/jcb.26739.
Google Scholar | Crossref | Medline7. Weng, L, Shen, S, Wu, S, et al. Identification of Critical Genes and Proteins for Stent Restenosis Induced by Esophageal Benign Hyperplasia in Esophageal Cancer. Front Genet 2020; 11: 563954. DOI: 10.3389/fgene.2020.563954.
Google Scholar | Crossref | Medline8. Evellin, S, Galvagni, F, Zippo, A, et al. FOSL1 controls the assembly of endothelial cells into capillary tubes by direct repression of alphav and beta3 integrin transcription. Mol Cel Biol 2013; 33: 1198–1209. DOI: 10.1128/MCB.01054-12.
Google Scholar | Crossref | Medline9. Sobolev, VV, Zolotarenko, AD, Soboleva, AG, et al. [Expression of the FOSL1 gene in psoriasis and atherosclerosis]. Genetika 2010; 46: 104–110.
Google Scholar | Medline10. Kim, SJ, Pham, TH, Bak, Y, et al. Orientin inhibits invasion by suppressing MMP-9 and IL-8 expression via the PKCalpha/ERK/AP-1/STAT3-mediated signaling pathways in TPA-treated MCF-7 breast cancer cells. Phytomedicine 2018; 50: 35–42. DOI: 10.1016/j.phymed.2018.09.172.
Google Scholar | Crossref | Medline11. Fujisawa, T, Joshi, BH, Puri, RK. IL-13 regulates cancer invasion and metastasis through IL-13Ralpha2 via ERK/AP-1 pathway in mouse model of human ovarian cancer. Int J Cancer 2012; 131: 344–356. DOI: 10.1002/ijc.26366.
Google Scholar | Crossref | Medline | ISI12. Zheng, YM, Xie, LQ, Li, X, et al. [Effect of ERK/AP-1 signaling pathway on proliferation of hepatoma cells induced by PAR-2 agonists]. Zhonghua Yi Xue Za Zhi 2009; 89: 3116–3121.
Google Scholar | Medline13. Han, Y, Zhao, X, Sun, Y, et al. Effects of FOSL1 silencing on osteosarcoma cell proliferation, invasion and migration through the ERK/AP-1 signaling pathway. J Cel Physiol 2019; 234: 3598–3612. DOI: 10.1002/jcp.27048.
Google Scholar | Crossref | Medline14. Peng, H, Zhang, K, Liu, Z, et al. VPO1 Modulates Vascular Smooth Muscle Cell Phenotypic Switch by Activating Extracellular Signal-regulated Kinase 1/2 (ERK 1/2) in Abdominal Aortic Aneurysms. J Am Heart Assoc 2018; 7: e010069. DOI: 10.1161/JAHA.118.010069.
Google Scholar | Crossref | Medline15. Zou, Y, Qi, Y, Roztocil, E, et al. Patterns of kinase activation induced by injury in the murine femoral artery. J Surg Res 2007; 142: 332–340. DOI: 10.1016/j.jss.2007.05.033.
Google Scholar | Crossref | Medline | ISI16. Ray, JL, Leach, R, Herbert, JM, et al. Isolation of vascular smooth muscle cells from a single murine aorta. Methods Cel Sci 2001; 23: 185–188. DOI: 10.1023/a:1016357510143.
Google Scholar | Crossref | Medline17. Kucukseymen, S . Inflammation Effects on Stent Restenosis. Angiology 2017; 68: 741. DOI: 10.1177/0003319717701659.
Google Scholar | SAGE Journals | ISI18. Lee, S, Byun, JK, Park, M, et al. Melatonin inhibits vascular smooth muscle cell proliferation and apoptosis through upregulation of Sestrin2. Exp Ther Med 2020; 19: 3454–3460. DOI: 10.3892/etm.2020.8638.
Google Scholar | Crossref | Medline19. Feng, L, Dou, C, Wang, J, et al. Upregulated 1433beta aggravates restenosis by promoting cell migration following vascular injury in diabetic rats with elevated levels of free fatty acids. Int J Mol Med 2018; 42: 1074–1085. DOI: 10.3892/ijmm.2018.3671.
Google Scholar | Crossref | Medline20. Lv, L, Zhang, J, Zhang, L, et al. Essential role of Pin1 via STAT3 signalling and mitochondria-dependent pathways in restenosis in type 2 diabetes. J Cel Mol Med 2013; 17: 989–1005. DOI: 10.1111/jcmm.12082.
Google Scholar | Crossref | Medline21. Moshapa, FT, Riches-Suman, K, Palmer, TM. Therapeutic Targeting of the Proinflammatory IL-6-JAK/STAT Signalling Pathways Responsible for Vascular Restenosis in Type 2 Diabetes Mellitus. Cardiol Res Pract 2019: 9846312. DOI: 10.1155/2019/9846312.
Google Scholar | Crossref | Medline22. Wei, W, Li, XX, Xu, M. Inhibition of vascular neointima hyperplasia by FGF21 associated with FGFR1/Syk/NLRP3 inflammasome pathway in diabetic mice. Atherosclerosis 2019; 289: 132–142. DOI: 10.1016/j.atherosclerosis.2019.08.017.
Google Scholar | Crossref | Medline

留言 (0)

沒有登入
gif